Outset Medical Statistics
Total Valuation
Outset Medical has a market cap or net worth of $200.17 million. The enterprise value is $172.43 million.
| Market Cap | 200.17M |
| Enterprise Value | 172.43M |
Important Dates
The next estimated earnings date is Wednesday, July 31, 2024, after market close.
| Earnings Date | Jul 31, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Outset Medical has 51.72 million shares outstanding. The number of shares has increased by 4.34% in one year.
| Shares Outstanding | 51.72M |
| Shares Change (YoY) | +4.34% |
| Shares Change (QoQ) | +1.28% |
| Owned by Insiders (%) | 1.79% |
| Owned by Institutions (%) | 100.40% |
| Float | 50.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.60 |
| Forward PS | 1.24 |
| PB Ratio | 2.15 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.38 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.42, with a Debt / Equity ratio of 2.17.
| Current Ratio | 6.42 |
| Quick Ratio | 5.26 |
| Debt / Equity | 2.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -9.72 |
Financial Efficiency
Return on equity (ROE) is -122.50% and return on invested capital (ROIC) is -55.19%.
| Return on Equity (ROE) | -122.50% |
| Return on Assets (ROA) | -51.80% |
| Return on Capital (ROIC) | -55.19% |
| Revenue Per Employee | $260,577 |
| Profits Per Employee | -$351,604 |
| Employee Count | 480 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.82 |
Taxes
In the past 12 months, Outset Medical has paid $493,000 in taxes.
| Income Tax | 493,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -79.77% in the last 52 weeks. The beta is 1.99, so Outset Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.99 |
| 52-Week Price Change | -79.77% |
| 50-Day Moving Average | 3.91 |
| 200-Day Moving Average | 4.00 |
| Relative Strength Index (RSI) | 47.40 |
| Average Volume (20 Days) | 1,285,177 |
Short Selling Information
The latest short interest is 8.56 million, so 16.55% of the outstanding shares have been sold short.
| Short Interest | 8.56M |
| Short Previous Month | 8.71M |
| Short % of Shares Out | 16.55% |
| Short % of Float | 16.87% |
| Short Ratio (days to cover) | 6.73 |
Income Statement
In the last 12 months, Outset Medical had revenue of $125.08 million and -$168.77 million in losses. Loss per share was -$3.37.
| Revenue | 125.08M |
| Gross Profit | 30.79M |
| Operating Income | -163.20M |
| Pretax Income | -168.28M |
| Net Income | -168.77M |
| EBITDA | -145.37M |
| EBIT | -152.58M |
| Loss Per Share | -$3.37 |
Balance Sheet
The company has $230.25 million in cash and $202.51 million in debt, giving a net cash position of $27.74 million or $0.54 per share.
| Cash & Cash Equivalents | 230.25M |
| Total Debt | 202.51M |
| Net Cash | 27.74M |
| Net Cash Per Share | $0.54 |
| Equity (Book Value) | 93.20M |
| Book Value Per Share | 1.80 |
| Working Capital | 274.72M |
Cash Flow
In the last 12 months, operating cash flow was -$132.53 million and capital expenditures -$2.98 million, giving a free cash flow of -$135.51 million.
| Operating Cash Flow | -132.53M |
| Capital Expenditures | -2.98M |
| Free Cash Flow | -135.51M |
| FCF Per Share | -$2.66 |
Margins
Gross margin is 24.61%, with operating and profit margins of -130.48% and -134.93%.
| Gross Margin | 24.61% |
| Operating Margin | -130.48% |
| Pretax Margin | -134.54% |
| Profit Margin | -134.93% |
| EBITDA Margin | -116.22% |
| EBIT Margin | -121.99% |
| FCF Margin | -108.34% |
Dividends & Yields
Outset Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -4.34% |
| Shareholder Yield | -4.34% |
| Earnings Yield | -84.32% |
| FCF Yield | -67.70% |
Analyst Forecast
The average price target for Outset Medical is $5.30, which is 36.95% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.30 |
| Price Target Difference | 36.95% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 17.63% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Outset Medical has an Altman Z-Score of -3.72 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.72 |
| Piotroski F-Score | 3 |